Carcinogens in the nose and throat: nasopharyngeal carcinoma in Kenya.

Following the report by Todd (1921), subsequent studies (Digby et al. 1930, Digby et al. 1941, Digby 1951, Hu & Yang 1959) showed nasopharyngeal carcinoma (NPC) to be common in Chinese. Muir (1971) estimated incidence rates for Chinese as 10-20 per 100 000 population annually for males and 5-10 for females, and Ho (1967) has reported an annual incidence of 25.2 per 100 000 for males and 12.4 for females in Hong Kong. Within China the incidence of this disease appears to relate to latitude and these high rates apply only to the South China provinces of Kwantung, Kwangsi and Fukien. Reports from Central and North China indicate that this disease is less prevalent in these areas (Clifford 1970a). Nasopharyngeal carcinoma is rare in the mongoloid peoples of Korea and Japan who are descendants of peoples migrating from the mainland of Asia, mainly Manchuria. For centuries Chinese from South China have migrated and settled throughout the countries of South-east Asia and the Americas. Intermarriage has occurred with the original native inhabitants of these countries. In some instances it has been possible to compare the incidence of NPC in population groups of pure Chinese, mixed Chinese/indigenous, and indigenous stock. In areas such as Singapore, Malaya, Thailand and Indonesia the highest incidences occur in the pure Chinese groups, with rates comparable to but lower than those noted in South China. The lowest rates occur in indigenous native populations and intermediate levels in those with an admixture of Chinese blood (Muir 1971). This association has suggested that the disease may be genetically determined, but this needs reappraisal. Cancer arising as the result of the exposure of a racial group or section of the population to common environmental carcinogens may erroneously be ascribed to an inherited genetic susceptibility. Neither have significant external environmental factors been found affecting these population groups, perhaps because attention has been concentrated almost entirely on the search for carcinogenic inhalants. However, the importance of environmental factors is indicated by analyses of cases by birth in Hawaii, Australia and California which have shown a significantly lower incidence in those Chinese born outside China than in those born in China (reviewed by Clifford 1970a). NPC is rare in the caucasian peoples of Europe, India and America. In populations of European origin the relative frequency of this disease is about 0.3% in males and 0.2% in females. In India and Ceylon this cancer occurs as 0.5% of all cancers. Muir estimates the incidence in occidental countries as less than 1 per 100 000. The occurrence of NPC in Africa has only recently been recognized, though the oldest known pathological specimens are derived from

[1]  P. Clifford,et al.  Nasopharyngeal Cancer in Kenya , 1964, British Journal of Cancer.

[2]  G. Klein,et al.  Epstein‐Barr virus (EBV)‐associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease , 1970, International journal of cancer.

[3]  C. Wells Ancient Egyptian Pathology , 1963, The Journal of Laryngology & Otology.

[4]  W. Henle,et al.  Infectious Mononucleosis: Clinical Manifestations in Relation to EB Virus Antibodies , 1968 .

[5]  K. Shanmugaratnam,et al.  The plasma levels of dehydroepiandrosterone sulphate, androsterone sulphate, cortisol and transcortin in Chinese, Indian and Malay males. , 1969, Singapore medical journal.

[6]  G. Klein,et al.  Epstein-Barr virus-associated antibody patterns in carcinoma of the post-nasal space. , 1969, Clinical and experimental immunology.

[7]  P. Rous,et al.  THE CARCINOGENIC EFFECT OF A PAPILLOMA VIRUS ON THE TARRED SKIN OF RABBITS : I. DESCRIPTION OF THE PHENOMENON. , 1938, The Journal of experimental medicine.

[8]  G. Klein,et al.  COMPLEXITY OF ANTIGEN‐ANTIBODY SYSTEMS ASSOCIATED WITH EPSTEIN‐BARR VIRUS * , 1971, Annals of the New York Academy of Sciences.

[9]  V. Diehl,et al.  Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. , 1969, Journal of the National Cancer Institute.

[10]  G. Klein,et al.  Effect of local radiotherapy on the antibody levels against ebv‐induced early and capsid antigens (ea and vca) in patients with certain malignant tumours , 1972, International journal of cancer.

[11]  C. Muir,et al.  Nasopharyngeal carcinoma in non‐chinese populations with special reference to South‐East Asia and Africa , 1971, International journal of cancer.

[12]  G. Klein,et al.  Epstein‐barr virus (EBV)‐associated antibody patterns in malignant lymphoma and leukemia. II. Chronic lymphocytic leukemia and lymphocytic lymphoma , 1971, International journal of cancer.

[13]  P. Clifford Carcinoma of the nasopharynx in Kenya. , 1965, East African medical journal.

[14]  P. Clifford,et al.  Plasma-testosterone levels in Kenyan men in relation to cancer of the nasopharynx. , 1966, Lancet.

[15]  M. Epstein,et al.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.

[16]  V. Diehl,et al.  Infectious mononucleosis in East Africa. , 1969, East African medical journal.

[17]  C. Hu,et al.  A decade of progress in morphologic pathology. , 1959, Chinese medical journal.

[18]  S. F. Petropulos,et al.  Enhancement of responses to chemical carcinogens by nononcogenic viruses and antimetabolites. , 1969, Progress in experimental tumor research.

[19]  M. L. Duran-Reynals COMBINED EFFECTS OF CHEMICAL CARCINOGENIC AGENTS AND VIRUSES. , 1963, Progress in experimental tumor research.

[20]  C. Linsell,et al.  Cancer in Africa. A selection of papers given at the East African Medical Research Council Scientific Conference in Nairobi in January 1967. , 1968 .

[21]  M. J. Shear,et al.  Studies in Carcinogenesis. XII. Effect of the Basic Fraction of Creosote Oil on the Production of Tumors in Mice By Chemical Carcinogens , 1940 .

[22]  P. Clifford,et al.  Plasma-levels of the sulphate esters of dehydroepiandrosterone and androsterone in Kenyan men and their relation to cancer of the nasopharynx. , 1968, Lancet.

[23]  V. Diehl,et al.  Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. , 1970, Journal of the National Cancer Institute.

[24]  P. Clifford On the epidemiology of nasopharyngeal carcinoma , 1970 .

[25]  A. Shaper,et al.  Medicine in a Tropical Environment , 1973, Journal of the Royal College of Physicians of London.

[26]  Blood-groups and nasopharyngeal carcinoma. , 1970, Lancet.

[27]  I. Berenblum The Cocarcinogenic Action of Croton Resin , 1941 .

[28]  P. Clifford,et al.  Endocrine studies in African males with nasopharyngeal cancer. , 1966, Lancet.

[29]  R. Burrell,et al.  Esophageal cancer in the Bantu of the Transkei associated with mineral deficiency in garden plants. , 1966, Journal of the National Cancer Institute.

[30]  K. Digby Nasopharyngeal Carcinoma: Otolaryngology Lecture delivered at the Royal College of Surgeons of England under the auspices of the Institute of Laryngology and Otology* on 5th July, 1951 , 1951 .

[31]  R. J. Harris Proceedings of the 9th International Cancer Congress , 1967, UICC Monograph Series.

[32]  G. Klein,et al.  Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx , 1970, Nature.